U.S. Markets closed

Tilray, Inc. (TLRY)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
19.70+1.14 (+6.14%)
At close: 4:00PM EST

Tilray, Inc.

1100 Maughan Road
Nanaimo, BC V9X IJ2

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees1,646

Key Executives

NameTitlePayExercisedYear Born
Mr. Brendan KennedyChairman, Pres & CEO592.15k6.35M1972
Mr. Andrew PucherChief Corp. Devel. Officer253.99kN/A1983
Mr. Michael C. KruteckChief Financial OfficerN/AN/A1962
Mr. Jon Edward LevinChief Operating OfficerN/AN/A1969
Ms. Dara RedlerGen. Counsel & Corp. Sec.N/AN/AN/A
Ms. Rita SeguinChief HR OfficerN/AN/AN/A
Mr. Greg ChristopherExec. VP of OperationsN/AN/AN/A
Mr. Sascha MielcarekManaging Director of EuropeN/AN/AN/A
Mr. Josh EadesChief Science OfficerN/AN/AN/A
Mr. John AndonoffSr. VP of Global Medical Sales Devel.N/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products to patients, physicians, pharmacies, governments, and hospitals; and for researchers for commercial purposes, as well as compassionate access and clinical research applications. It operates in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, Israel, Ireland, New Zealand, South Africa, Switzerland, the United States, and the United Kingdom. The company was incorporated in 2018 and is headquartered in Nanaimo, Canada.

Corporate Governance

Tilray, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.